Onpattro (Patisiran Lipid Complex Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

SoluPrep (Film-Forming Sterile Surgical Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

Annovera (Segesterone Acetate and Ethinyl Estradiol Vaginal System) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

Arakoda (Tafenoquine Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

erythromycin (Ery-Tab, PCE)
Title: erythromycin (Ery-Tab, PCE)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/16/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

Benzodiazepines vs. Barbiturates
Title: Benzodiazepines vs. BarbituratesCategory: MedicationsCreated: 8/16/2018 12:00:00 AMLast Editorial Review: 8/16/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

Evoke Pharma ’s Gimoti NDA Accepted for FDA Review
SOLANA BEACH, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company ’s 505(b)(2) New Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

Fecal Transplant for Severe Refractory C. Difficile Infection Fecal Transplant for Severe Refractory C. Difficile Infection
This RCT compared the efficacy of two fecal microbiota transplant protocols associated with vancomycin in curing patients with severe Clostridium difficile infection refractory to antibiotics.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 16, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

RPS supports increased role of pharmacists in hospital discharge
A national review to evaluate the quality of hospital discharge in Wales has called for the introduction of ward-based pharmacists to help improve medication lists and the production of timely dischar (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

WP-Thyroid (Thyroid Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

NP-Thyroid (Thyroid Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

Poteligeo (Mogamulizumab-kpkc Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

Nuvessa (Metronidazole Vaginal Gel) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

Tripedia (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

Soltamox (Tamoxifen Citrate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

Ortho Dermatologics Resubmits U.S. New Drug Application for Duobrii (halobetasol propionate and tazarotene) Lotion
LAVAL, Quebec, Aug. 15, 2018 /PRNewswire/ -- Ortho Dermatologics, a division of Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced it has resubmitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Kalydeco (ivacaftor) for Cystic Fibrosis in Children Ages 12 to & lt;24 Months with Certain Mutations in the CFTR Gene
BOSTON--(BUSINESS WIRE)--Aug. 15, 2018-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved Kalydeco (ivacaftor) to include use in children with cystic fibrosis (CF) ages 12 to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 15, 2018 Category: Drugs & Pharmacology Source Type: news

Ustekinumab for Crohn's Disease: Long-term Efficacy, Safety Ustekinumab for Crohn's Disease: Long-term Efficacy, Safety
This study assessed long-term extension data of ustekinumab for Crohn's disease, demonstrating the maintenance of response and remission and continued safety through 92 weeks.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 14, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Motif Bio Announces FDA Acceptance of New Drug Application With Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the U.S. Food& Drug Administration (FDA) has accepted... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 14, 2018 Category: Drugs & Pharmacology Source Type: news

Drug repurposing study sheds light on heart disease risk
(Brigham and Women's Hospital) A team led by researchers at Brigham and Women's Hospital has developed a computational technique to reveal the unknown side effects -- both good and bad -- of hundreds of drugs. That knowledge could help pharmacologists discover new indications for drugs already on the market and repurpose them for other disorders. Using their unique method, the researchers discovered that two drugs commonly prescribed for non-coronary disorders may affect heart disease risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 14, 2018 Category: International Medicine & Public Health Source Type: news

MHRA issues further information on valproate use by women and girls
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a video to help healthcare professionals in implementing the new 2018 regulatory measures, including the pregnancy prevention (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 13, 2018 Category: Drugs & Pharmacology Source Type: news

Nitrolingual Pumpspray (Nitroglycerin Lingual Spray) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 13, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters
Brussels (Belgium)& Atlanta Georgia, August 13th 07:00 (CEST): UCB today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for midazolam nasal spray*, an investigational product... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 13, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Galafold (migalastat) for the Treatment of Fabry Disease
August 10, 2018 -- The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults with Fabry disease who have a genetic mutation... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 11, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ -- The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera ™ (segesterone acetate and ethinyl estradiol vaginal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 10, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Onpattro (patisiran) Targeted RNA-based Therapy for Polyneuropathy Caused by hATTR
August 10, 2018 -- The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 10, 2018 Category: Drugs & Pharmacology Source Type: news

Resources to support the safe and timely management of hyperkalaemia (high level of potassium in the blood)
NHS Improvement has issued a Patient Safety Alert to support the safe and timely management of hyperkalaemia. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 10, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Jornay PM (methylphenidate) Extended-Release Capsules for Attention Deficit Hyperactivity Disorder (ADHD)
GEORGE TOWN, Cayman Islands--(BUSINESS WIRE)August 09, 2018 --Ironshore Pharmaceuticals& Development, Inc. ( “Ironshore”) a wholly owned subsidiary of Highland Therapeutics Inc. (“Highland”) announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Arakoda (tafenoquine) for the Prevention of Malaria
WASHINGTON, Aug. 9, 2018 /PRNewswire/ -- 60 Degrees Pharmaceuticals (60P) announced today the U.S. Food and Drug Administration (FDA) approval of Arakoda (tafenoquine) tablets for the prevention of malaria in patients aged 18 years and older. For... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Fluorescein Sodium Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Labetalol Hydrochloride Injection (New - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Royal Pharmaceutical Society acquires PalliativeDrugs.com
The Royal Pharmaceutical Society (RPS) is pleased to announce the acquisition of Palliativedrugs.com, the publisher of the Palliative Care Formulary and Introducing Palliative Care, key resources for (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Restrictions to the use of Esmya (ulipristal acetate) for the symptoms of uterine fibroids and the requirement to check liver function
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a letter for healthcare professionals - Esmya (ulipristal acetate) for symptoms of uterine fibroids: restrictions to use and r (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Royal Pharmaceutical Society acquires Palliativedrugs.com
The Royal Pharmaceutical Society (RPS) is pleased to announce the acquisition of Palliativedrugs.com, the publisher of the Palliative Care Formulary and Introducing Palliative Care, key resources for (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Pondimin (Fenfluramine - Removed from US Market) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

SecreFlo (Secretin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

The Prevention of HBV-Related Hepatocellular Carcinoma The Prevention of HBV-Related Hepatocellular Carcinoma
This article discusses risk stratification of HBV-related hepatocellular carcinoma and summarizes three levels of preventive strategies.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 9, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Poteligeo (mogamulizumab-kpkc) for Mycosis Fungoides and S ézary Syndrome
August 8, 2018 -- The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or S ézary syndrome (SS) after... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Sodium Chloride Injection USP, 0.9% Vials and Syringes (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Aminophylline Injection, USP (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

La FDA advierte acerca del incremento del riesgo de reincidencia del c áncer con el uso del antibiótico azitromicina (Zithromax, Zmax) a largo plazo posterior a un trasplante de células madre de donante
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

La FDA advierte acerca del incremento del riesgo de reincidencia del c á ncer con el uso del antibi ó tico azitromicina (Zithromax, Zmax) a largo plazo posterior a un trasplante de c é lulas madre de donante
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Membership Fees 2019
The RPS Assembly has agreed a 2.4% inflation-linked increase in membership fees for 2019 based on the Consumer Price Index at theend of May 2018. The new membership subscriptions that will take effec (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Azedra (Iobenguane I 131 Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Omegaven (Fish Oil Triglycerides Injectable Emulsion) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Advisory Committee Recommends Approval of Paratek ’s Omadacycline
BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the Antimicrobials Drug Advisory Committee of the U.S. Food and Drug Administration voted in favor of the approval of intravenous (IV) and... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

Can medical marijuana help treat intractable epilepsy?
(Wiley) A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis -- or medical marijuana -- for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 8, 2018 Category: International Medicine & Public Health Source Type: news

FDA Approves Expanded Indication for Orkambi (lumacaftor/ivacaftor) in Children Ages 2-5 Years
BOSTON--(BUSINESS WIRE)--Aug. 7, 2018-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved Orkambi (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 7, 2018 Category: Drugs & Pharmacology Source Type: news

Sacrosidase (Sucraid) Oral Solution (Updated - Currently in Shortage)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 7, 2018 Category: Drugs & Pharmacology Source Type: news